Evidence map›Paper›PMID 38604791›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Diagnosis and treatment understanding of Waldenström macroglobulinemia in China: a cross-sectional study].

S H Yi, W J Xiong, X X Cao, C Y Sun, J Du, H H Wang, L Wang, T Niu, Z X Jiang, Y Q Wei and 4 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

S H YiState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.
W J XiongState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.
X X CaoPeking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
C Y SunUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
J DuThe Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), Shanghai 200003, China.
H H WangShengjing Hospital of China Medical University, Shenyang 110004, China.
L WangShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
T NiuWest China Hospital of Sichuan University, Chengdu 610044, China.
Z X JiangThe First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Y Q WeiNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H XueThe Affiliated Hospital of Hebei University, Baoding 071030, China.
H L ChuPeking University Third Hospital, Beijing 100083, China.
L G QiuState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.
J LiPeking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

Funding

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2022-I2M-1-022 and 2021-I2M-C&T-B-081
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Waldenstrom MacroglobulinemiaCross-Sectional StudiesHumansMyeloid Differentiation Factor 88Protein Kinase InhibitorsSignal TransductionSurveys and QuestionnairesMyeloid Differentiation Factor 88Protein Kinase InhibitorsCross-sectional studyDiagnosis and treatment understandingPhysician surveyWaldenström macroglobulinemia

Identifiers

PMID38604791
PMCPMC11078679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.